Prostatype Genomics AB (publ)
Prostatype Genomics AB manufactures, markets, and sells prognostic gene tests. The company offers Prostatype Test System that combines gene expression information with used clinical parameters, such as PSA, gleason score, and tumor stage, as well as calculates the P-score. Its test is based on database containing prostate cancer patients; and provides decision support for patients and doctors whe… Read more
Prostatype Genomics AB (publ) (PGABF) - Net Assets
Latest net assets as of : $- USD
Based on the latest financial reports, Prostatype Genomics AB (publ) (PGABF) has net assets worth $- USD as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($-) and total liabilities ($-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
Prostatype Genomics AB (publ) - Net Assets Trend (None–None)
This chart illustrates how Prostatype Genomics AB (publ)'s net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Prostatype Genomics AB (publ) (None–None)
The table below shows the annual net assets of Prostatype Genomics AB (publ) from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to Prostatype Genomics AB (publ)'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
Prostatype Genomics AB (publ) Competitors by Market Cap
The table below lists competitors of Prostatype Genomics AB (publ) ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
ATOM EDUC ON
SA:ATED3
|
$3.40K |
|
Thorney Opportunities Ltd
AU:TOP
|
$3.41K |
|
Fateh Sports Wear Limited
KAR:FSWL
|
$3.41K |
|
Aztec
WAR:AZC
|
$3.41K |
|
HAGA3F
SA:HAGA3F
|
$3.40K |
|
Galvo
WAR:GAL
|
$3.40K |
|
PT Indocement Tunggal Prakarsa Tbk
BE:ITP
|
$3.39K |
|
HNB Assurance PLC
CM:HASUN0000
|
$3.39K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Prostatype Genomics AB (publ)'s equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares Prostatype Genomics AB (publ)'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently Prostatype Genomics AB (publ) utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares Prostatype Genomics AB (publ)'s net assets metrics with peer companies in the same industry.
Industry Context
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Prostatype Genomics AB (publ) (PGABF) | $- | N/A | N/A | $3.40K |
| Abcam plc (ABCZF) | $726.90 Million | -1.17% | 0.45x | $5.00 Billion |
| Able View Global Inc. Warrant (ABLVW) | $11.42 Million | 85.41% | 3.81x | $277.93K |
| Above Food Ingredients Inc. Warrants (ABVEW) | $199.86 Million | -2.89% | 0.00x | $6.25 Million |
| Adamas Trust, Inc. (ADAMG) | $2.43 Billion | 7.94% | 1.33x | $2.09 Billion |
| ADS-TEC ENERGY PLC Warrant (ADSEW) | $33.92 Million | -162.39% | 2.67x | $10.06 Million |
| Alliance Entertainment Holding Corporation Warrants (AENTW) | $52.92 Million | 10.13% | 4.23x | $2.29 Million |
| Forafric Global PLC Warrants (AFRIW) | $5.32 Million | -457.58% | 45.29x | $2.67 Million |
| Centurion Acquisition Corp. Warrant (ALFUW) | $282.84 Million | 1.97% | 0.05x | $4.81 Million |
| Alliance Trust PLC (ALITF) | $4.04 Billion | 10.04% | 0.29x | $112.87K |
| Alvotech Warrant (ALVOW) | $-564.42 Million | 0.00% | 0.00x | $35.01 Million |